摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(3-piperidin-1-yl-propoxy)-1,3,4,5-tetrahydro-benzo[c]azepine-2-carboxilic acid tert-butyl ester | 667398-67-6

中文名称
——
中文别名
——
英文名称
7-(3-piperidin-1-yl-propoxy)-1,3,4,5-tetrahydro-benzo[c]azepine-2-carboxilic acid tert-butyl ester
英文别名
Tert-butyl 7-(3-piperidin-1-ylpropoxy)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate
7-(3-piperidin-1-yl-propoxy)-1,3,4,5-tetrahydro-benzo[c]azepine-2-carboxilic acid tert-butyl ester化学式
CAS
667398-67-6
化学式
C23H36N2O3
mdl
——
分子量
388.55
InChiKey
PNQOYJJMGAKJFE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    28
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    42
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED AZEPINES AS HISTAMINE H3 RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES<br/>[FR] AZEPINES SUBSTITUEES UTILISEES COMME ANTAGONISTES DES RECEPTEURS H3 DE L'HISTAMINE, LEUR PREPARATION ET LEURS UTILISATIONS THERAPEUTIQUES
    申请人:LILLY CO ELI
    公开号:WO2004018432A1
    公开(公告)日:2004-03-04
    The present invention discloses novel substituted azepine compounds of Formula (I) or pharmaceutically acceptable salts thereof which have selective histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such azepines as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.
    本发明公开了新型的Formula (I)的取代氮杂环庚烷化合物或其药学上可接受的盐,其具有选择性组胺-H3受体拮抗活性,以及制备这些化合物的方法。在另一实施方案中,本发明公开了包含这些氮杂环庚烷化合物的药物组合物,以及利用它们治疗肥胖和其他组胺H3受体相关疾病的方法。
  • Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
    申请人:Gadski Alan Robert
    公开号:US20060089347A1
    公开(公告)日:2006-04-27
    The present invention discloses novel substituted azepine compounds of Formula (I) or pharmaceutically acceptable salts thereof which have selective histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such azepines as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.
    本发明披露了一种新型的取代的氮杂七环化合物,其化学式为(I),或其药学上可接受的盐,具有选择性的组胺H3受体拮抗作用,以及制备这种化合物的方法。在另一种实施方案中,本发明披露了包含这样的氮杂七环化合物的制药组合物,以及使用它们治疗肥胖和其他组胺H3受体相关疾病的方法。
  • SUBSTITUTED AZEPINES AS HISTAMINE H3 RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES
    申请人:ELI LILLY AND COMPANY
    公开号:EP1539704A1
    公开(公告)日:2005-06-15
  • Synthesis and SAR of novel histamine H3 receptor antagonists
    作者:Cynthia D. Jesudason、Lisa S. Beavers、Jeffrey W. Cramer、Joelle Dill、Don R. Finley、Craig W. Lindsley、F. Craig Stevens、Robert A. Gadski、Samuel W. Oldham、R. Todd Pickard、Christopher S. Siedem、Dana K. Sindelar、Ajay Singh、Brian M. Watson、Philip A. Hipskind
    DOI:10.1016/j.bmcl.2006.04.004
    日期:2006.7
    The synthesis and biological evaluation of novel tetrahydroisoquinoline, tetrahydroquinoline, and tetrahydroazepine antagonists of the human and rat H-3 receptors are described. The substitution around these rings as well as the nature of the substituent on nitrogen is explored. Several compounds with high affinity and selectivity for the human and rat H-3 receptors are reported. (c) 2006 Elsevier Ltd. All rights reserved.
查看更多